← Leaderboards
Shounak Majumder
Mayo Clinic Rochester
$1,478,216
Attributed
$2,956,431
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $812.4K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,956,431 · 1
By mechanism
U01$2,956,431 · 1
Top collaborators
- Kenneth S Zaret4 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Peter C. Harris$28,592,075
- Scott H Kaufmann$29,002,745
- Andrew Lewis Feldman$5,717,562
- Neera Kanhouwa Dahl$190,281
Others in their field
Other Rising Stars on “Clinical Translation”
- Gary Mays · Axle Informatics, Llc$73,744,288
- Mari Ostendorf · University Of Washington$51,931,230
- Brian Zavertnik · Palantir Technologies, Inc.$37,240,166
- Bambra Stokes · Ppd Development Lp$17,155,112
- Kevin V Grimes · Stanford University$14,783,804
- Michael Hogarth · University Of California, San Diego$14,390,863
Research focus
Clinical TranslationBiobankAlgorithmsBiological Specimen BanksBiomarker DevelopmentBiomarker PanelBiomarker ValidationBiological MarkersBlindedBloodBlood ProductBlood ProteinsBlood SpecimenCa-19-9 AntigenCancer DetectionCancer EtiologyCancer-Predisposing GeneBiometryCenters Of Research ExcellenceCessation Of LifeCharacteristicsClinicClinical EffectCohort
Grant awards (4)
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer$701,671
U01 · FY2025 · CA · contact PI
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer$660,703
U01 · FY2024 · CA · contact PI
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer$781,677
U01 · FY2023 · CA · contact PI
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer$812,380
U01 · FY2022 · CA · contact PI